Sinovac COVID-19 vaccine granted conditional market approval in China

Source: Xinhua| 2021-02-06 21:45:14|Editor: huaxia

A staff member of Sinovac Biotech, a Chinese biopharmaceutical company, displays two doses of COVID-19 inactivated vaccine in prefilled syringes in Beijing, capital of China, Dec. 23, 2020. China's National Medical Products Administration on Friday granted conditional market approval to CoronaVac, an inactivated COVID-19 vaccine developed by Sinovac Biotech, the company said on Saturday. (Xinhua/Zhang Yuwei)

   Prev 1 2 3 4 5 6 7 8 9  

KEY WORDS:
EXPLORE XINHUANET
010020070750000000000000011100001397265171